Bronchial hyperresponsiveness in a population of north Finland with no previous diagnosis of asthma or chronic bronchitis assessed with histamine and methacholine tests

Abstract

Objectives. To assess the prevalence of bronchial hyperresponsiveness (BHR) in a population of north Finland among subjects with no previous diagnosis of asthma or chronic bronchitis by using histamine and methacholine challenges. The agreement between the methods was also evaluated. Study design. An epidemiological study assessing the prevalence of BHR measured with direct dosimetric challenge methods. Methods. Seventy-nine randomly selected subjects ( 1-73 years) were studied; 67% had respiratory or allergic symptoms. The baseline spirometry was normal or showed mild obstruction. Bronchial challenges to methacholine and histamine were performed on each subject in a randomized order. Provocative doses inducing the decrease of FEV 1 by 15% and 0% (PD 15 FEV 1 and PD 0 FEV 1 ) and dose response ratios (DDR) were calculated for both tests. Results. BHR with the methacholine test (PD 0 FEV 1 ≤2.6 mg) was found in 20% and with the histamine test (PD 15 FEV 1 ≤1.6 mg) in 28% of subjects; the agreement was 80% (kappa 0.45; 95% CI 0. 3-0.68). In staging the severity of BHR the methods had a good agreement (weighted kappa 0.64; CI 95% 0.46-0.82). Prevalence of BHR fulfilling the criteria of the both methods was 14%. Conclusions. The findings suggest that the prevalence of BHR in the population of north Finland with no previous diagnosis of asthma or chronic bronchitis is at least 14%, probably around 0%, assessed by histamine and methacholine challenge methods. The methods have a good agreement to be used for classifying the severity of BHR. (Int J Circumpolar Health 2008; 67(4):308-317)

Bronchial hyperresponsiveness in an adult population in Helsinki: decreased FEV1, the main determinant

“…In this study, female gender and BHR showed no association in contrast with some other's findings (8, 41, 42). The explanation may, at least in part, depend on differences in cohorts’ lung-function values or the use of that data.…”

“…In Finland, the prevalence of physician-diagnosed asthma in adults has increased to 7% (6, 7), but epidemiologic data on BHR and its associations are available only from a selected study cohort from near the Arctic Circle (8). …”

Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults

“…Prevalence of BHR in the general Finnish population with no previous diagnosis of asthma or chronic bronchitis and with normal lung volumes is 17% [37]. In our study population, BHR occurred markedly more frequently in 41%, which is in accordance with the results of other studies [9,18,20,36].…”

Exhaled nitric oxide indicates poorly athlete's asthma

“…International guidelines of Bronchial Provocation Test still consider histamine and methacholine as alternative methods to express BHR. Methacholine and histamine are nearly equipotent direct bronchoconstrictors (30,31), and thereby histamine and methacholine positivity are likely to express the same pathophysiology in the study groups. In contrast, EVH represents indirect stimuli for the measurement of BHR, corresponding more closely exercise test (32) and is widely recommended for the diagnosis of EIB in athletes (13).…”